Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Oncotarget|November 20, 2018
Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progressionAmro Aboukameel, Irfana Muqbil, Erkan Baloglu, et al.ACS Medicinal Chemistry Letters|April 20, 2018
Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding SiteZhipeng Huo, Heng Zhang, Dongwei Kang, et al.Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7Songkai Sun, Boshi Huang, Zhuo Li, et al.NPJ Vaccines|July 11, 2023
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challengeViktor Lemmens, Lara Kelchtermans, Sarah Debaveye, et al.Journal of Virology|October 12, 2023
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1Pau Ribó-Molina, Hauke J Weiss, Balasubramanian Susma, et al.Biorxiv : the Preprint Server for Biology|October 17, 2024
Allosteric degraders induce CRL5 <sup>ASB8</sup> mediated degradation of XPO1Casey Elizabeth Hudman-Wing, Ho Yee Joyce Fung, Tolga Cagatay, et al.Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.Dalton Transactions (Cambridge, England : 2003)|August 16, 2012
CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocyclesRachel Smith, Dana Huskens, Dirk Daelemans, et al.Science Translational Medicine|June 29, 2018
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomasNatalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, et al.Chemmedchem|August 4, 2020
Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory ActivityTim Van de Walle, Marina Briand, Ana Mitrović, et al.Pageof 19